Catalyst Wire Dossier Catalyst Wire Dossier

Cord blood-derived CAR-NK cells (CD19-targeted)

CAR-NK cells targeting CD19 · Second Affiliated Hospital, School of Medicine, Zhejiang University
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cord blood-derived CAR-NK cells (CD19-targeted), covering 2025-03-04 to 2025-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Cord Blood-derived CAR-NK Cells Targeting CD19 in the Treatment of Refractory/Relapsed B-cell NHL [Phase 1]

See pricing